Status:
COMPLETED
Open-label Extension Study Of RN624
Lead Sponsor:
Pfizer
Conditions:
Osteoarthritis
OA Knee Pain
Eligibility:
All Genders
40-75 years
Phase:
PHASE2
Brief Summary
Study RN624-CL007 is planned to be an open-label protocol to enroll subjects who have previously participated in Study No. RN624-CL006. In this study, subjects will receive RN624 on an open-label basi...
Eligibility Criteria
Inclusion
- Enrolled in Study RN624-CL006
Exclusion
- The occurrence of any adverse event or condition during the controlled studies that, in the opinion of the Investigator, should exclude the subject from participating in the open-label extension
- Pregnant or lactating female subjects or subjects who do not agree to use an appropriate form of birth control throughout the study and for 3 months after completing the study
Key Trial Info
Start Date :
September 15 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 11 2008
Estimated Enrollment :
287 Patients enrolled
Trial Details
Trial ID
NCT00399490
Start Date
September 15 2006
End Date
February 11 2008
Last Update
February 2 2021
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
BrookWood Internal Medicine
Birmingham, Alabama, United States, 35209
2
Radiant Research
Birmingham, Alabama, United States, 35209
3
Arizona Research Center, LLC
Phoenix, Arizona, United States, 85023
4
Imaging Centers of Anaheim
Anaheim, California, United States, 92801